Agbotounou W K, Levitzki A, Jacquemin-Sablon A, Pierre J
U140 INSERM and URA147 CNRS Institut Gustave Roussy, Villejuif, France.
Mol Pharmacol. 1994 May;45(5):922-31.
Tyrphostins are synthetic compounds that have been described as in vitro and in vivo inhibitors of epidermal growth factor receptor tyrosine kinase activity. In NIH/3T3 cells transfected with the c-src/F527 gene, an increase in the level of tyrosine phosphorylation of several proteins, including pp125FAK, within a group of proteins of 120 kDa, of p85 (cortactin), and of p62 is observed, which is due to the elevated kinase activity of the resulting encoded pp60F527 protein. In the transfected cells, we showed that the tyrphostins we used, i.e., AG18, AG34, and AG82, strongly diminished the tyrosine phosphorylation of these proteins. Analysis of the steady state level of pp60F527 in tyr-phostin-treated cells revealed that AG34 and AG82, the two most potent compounds, also induced 30 and 48% decreases, respectively, in the amount of pp60F527, while having no action on the levels of other proteins, especially the pp60F527 kinase substrates. Measurement of the rates of pp60F527 synthesis and degradation showed that this decreased level was due to a slower rate of synthesis in the presence of AG34 and AG82. Tyrphostins also reversed the pp60F527-induced transformed morphology of NIH/3T3 cells and also inhibited the pp60F527 kinase activity in vitro. We conclude that the effects elicited by the tyrphostins occurred not only through the inhibition of the pp60F527 protein kinase activity but also through a selective reduction of the Src protein steady state level in the cases of AG34 and AG82. This is a novel mode of action for these two tyrphostins, which were the most active compounds in this system.
tyrphostins是一类合成化合物,已被描述为表皮生长因子受体酪氨酸激酶活性的体外和体内抑制剂。在转染了c-src/F527基因的NIH/3T3细胞中,观察到包括pp125FAK在内的一组120 kDa蛋白质、p85(皮层肌动蛋白)和p62中几种蛋白质的酪氨酸磷酸化水平增加,这是由于所产生的编码pp60F527蛋白的激酶活性升高所致。在转染细胞中,我们发现我们使用的tyrphostins,即AG18、AG34和AG82,能强烈降低这些蛋白质的酪氨酸磷酸化。对tyrphostin处理细胞中pp60F527的稳态水平分析表明,两种最有效的化合物AG34和AG82,还分别使pp60F527的量减少了30%和48%,而对其他蛋白质的水平没有影响,尤其是pp60F527激酶底物的水平。对pp60F527合成和降解速率的测量表明,这种降低的水平是由于在AG34和AG82存在下合成速率较慢所致。tyrphostins还逆转了pp60F527诱导的NIH/3T3细胞转化形态,并在体外抑制了pp60F527激酶活性。我们得出结论,tyrphostins所引发的效应不仅通过抑制pp60F527蛋白激酶活性发生,而且在AG34和AG82的情况下还通过Src蛋白稳态水平的选择性降低发生。这是这两种tyrphostins的一种新作用模式,它们是该系统中最具活性的化合物。